DUTASTERIDE | DUTASTERIDE | ATC G04CB02 ATC G04CA52
GENITO 5-ALPHA-REDUCTASE INHIBITOR TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA (BPH) | ORAL | Cmax 6.4 NANOMOLAR Tmax 2.5 HOUR F 60 PERCENT VD 400 LITER PPB 99 PERCENT Cl 0.33 LITER / HOUR (EQN) HT 840 HOUR SOLUBILITY INSOLUBLE IN WATER | 5 ALPHA-REDUCTASE | STEROID 5-ALPHA-REDUCTASE INHIBITOR CHEMBL2363075 STEROID 5-ALPHA-REDUCTASE P18405 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE 1 HOMO SAPIENS ENZYME REDUCTASE | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |